Target intelligence / Profile preview

Heat shock 70 kDa protein 1A (HSP70) (HSP70)

Target
HSP70
Molecular classification
Chaperone, Enzyme
01

Overview

Heat shock 70 kDa protein 1A (HSP70) is a ubiquitous molecular chaperone essential for maintaining cellular protein homeostasis by assisting in the folding of nascent polypeptides and the refolding of misfolded proteins (UniProt P0DMV8). It consists of an N-terminal nucleotide-binding domain (NBD) with ATPase activity and a C-terminal substrate-binding domain (SBD) that recognizes and binds to hydrophobic patches on misfolded or unfolded client proteins (PubMed: 29107545). In many cancers, HSP70 is overexpressed to support the stability of oncogenic client proteins and to inhibit apoptosis, making it a significant therapeutic target (PubMed: 25613110). In neurodegenerative diseases, the interaction of the HSP70 SBD with misfolded proteins like Tau or alpha-synuclein is explored to promote their clearance and prevent toxic aggregation (PubMed: 28235147). Small molecule inhibitors targeting the SBD or its allosteric communication with the NBD aim to disrupt these chaperone-client interactions, leading to the degradation of pathogenic proteins via the ubiquitin-proteasome system (PubMed: 19403813). Examples of such inhibitors include MKT-077 and Pifithrin-mu, which have shown potential in preclinical models of cancer and protein-misfolding disorders.

Other names
HSPA1AHSPA1BHSP72Heat shock 70 kDa protein 1Chaperone protein HSP70
02

Mechanism of action

Inhibition of the chaperone cycle by binding to the substrate-binding domain (SBD) or allosteric sites, preventing the stabilization of misfolded client proteins and promoting their degradation (PubMed: 25613110).

03

Biological functions

Protein foldingProteostasisApoptosisStress response
04

Disease associations

CancerNeurodegenerative diseaseInfection
05

Safety considerations

Systemic toxicity due to disruption of essential proteostasisInduction of the heat shock responseChallenges in isoform selectivity (PubMed: 29107545)
06

Interacting drugs

MKT-077

5 more in the full profile.

07

Biomarkers

HSP70 expression levelsClient protein degradation (e.g., Tau, Akt, HER2)HSP70-client complex levels

Beyond the preview

Go deeper on Heat shock 70 kDa protein 1A (HSP70) (HSP70).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock 70 kDa protein 1A (HSP70) (HSP70).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call